PT Millennium Pharmacon International Tbk (IDX:SDPC)

IDX:SDPC Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	45,849	53,473	58,900	25,668	47,362	48,054
Cash & Short-Term Investments	45,849	53,473	58,900	25,668	47,362	48,054
Cash Growth	219.36%	-9.21%	129.46%	-45.80%	-1.44%	62.95%
Accounts Receivable	855,896	731,940	659,684	545,672	440,453	476,368
Other Receivables	15,856	9,654	23,149	22,822	20,622	22,393
Receivables	871,753	741,593	682,833	568,494	461,074	498,761
Inventory	590,677	567,732	535,874	538,433	453,301	389,348
Prepaid Expenses	4,252	5,301	3,432	1,973	1,091	1,215
Other Current Assets	150,409	195,694	166,613	124,390	107,476	91,515
Total Current Assets	1,662,940	1,563,794	1,447,652	1,258,959	1,070,305	1,028,893
Property, Plant & Equipment	110,584	111,417	112,594	46,695	42,287	48,139
Long-Term Investments	22,508	22,508	33,300	54,000	54,000	54,000
Other Intangible Assets	7,718	7,779	9,142	8,737	-	-
Long-Term Deferred Tax Assets	19,509	17,056	16,576	14,489	17,309	6,861
Other Long-Term Assets	63,454	49,303	20,418	18,625	22,485	26,934
Total Assets	1,886,713	1,771,857	1,639,682	1,401,505	1,206,386	1,164,826
Accounts Payable	647,095	527,590	545,863	468,604	413,383	408,524
Accrued Expenses	28,902	22,604	25,873	20,961	13,441	37,354
Short-Term Debt	745,965	798,202	665,059	620,324	514,497	449,595
Current Portion of Long-Term Debt	65.41	5,009	-	-	-	-
Current Portion of Leases	-	-	358.33	468	432	396
Current Income Taxes Payable	7,457	114.47	1,424	1,429	453.33	-
Other Current Liabilities	77,974	59,897	48,422	1,252	382.8	7,389
Total Current Liabilities	1,507,458	1,413,417	1,287,001	1,113,038	942,589	903,258
Long-Term Debt	47,292	43,311	44,000	-	-	-
Long-Term Leases	-	-	918.22	1,510	1,798	2,030
Total Liabilities	1,590,021	1,489,360	1,361,969	1,142,595	969,406	935,630
Common Stock	127,400	127,400	127,400	127,400	127,400	127,400
Additional Paid-In Capital	2,310	2,310	2,310	2,310	2,310	2,310
Retained Earnings	187,364	173,167	159,951	129,200	107,270	99,487
Comprehensive Income & Other	-20,361	-20,361	-11,943	-	-	-
Total Common Equity	296,713	282,515	277,717	258,910	236,979	229,196
Minority Interest	-20.01	-18.57	-3.83	-	-	-
Shareholders' Equity	296,693	282,497	277,713	258,910	236,979	229,196
Total Liabilities & Equity	1,886,713	1,771,857	1,639,682	1,401,505	1,206,386	1,164,826
Total Debt	793,322	846,522	710,336	622,302	516,727	452,021
Net Cash (Debt)	-747,473	-793,049	-651,436	-596,633	-469,365	-403,967
Net Cash Per Share	-586.71	-622.49	-511.33	-468.32	-368.42	-317.09
Filing Date Shares Outstanding	1,274	1,274	1,274	1,274	1,274	1,274
Total Common Shares Outstanding	1,274	1,274	1,274	1,274	1,274	1,274
Working Capital	155,483	150,377	160,652	145,920	127,716	125,635
Book Value Per Share	232.90	221.75	217.99	203.23	186.01	179.90
Tangible Book Value	288,995	274,737	268,575	250,173	236,979	229,196
Tangible Book Value Per Share	226.84	215.65	210.81	196.37	186.01	179.90
Land	47,967	47,967	47,967	4,895	4,895	4,328
Buildings	10,653	10,515	6,278	7,412	8,084	7,806
Machinery	45,745	47,236	45,682	42,956	41,061	40,089
Construction In Progress	10,704	12,393	11,819	-	637.58	757.6
Leasehold Improvements	24,363	21,455	16,090	12,048	13,825	12,146

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.